Filter
660
Filtered Results: 660
Text search:
Zoonotic
diseases
Featured
Recommendations
72
New Publications
133
Language
Document type
No document type
206
Studies & Reports
186
Guidelines
128
Strategic & Response Plan
54
Fact sheets
33
Manuals
29
Training Material
8
Resource Platforms
8
Situation Updates
4
Online Courses
2
Infographics
1
Videos
1
Countries / Regions
Global
57
Africa
23
Latin America and the Carribbean
19
Sierra Leone
15
Liberia
14
India
14
Uganda
12
South Africa
11
Ethiopia
11
Nigeria
10
Kenya
9
Western and Central Europe
9
Tanzania
8
Rwanda
7
Guinea
7
West and Central Africa
7
South–East Asia Region
7
Asia
6
Ghana
5
East and Southern Africa
5
Nepal
4
Bangladesh
4
Brazil
4
Pakistan
4
Cameroon
3
Philippines
3
Venezuela
3
Congo, Democratic Republic of
3
Middle East and North Africa
3
Western Pacific Region
3
Sudan
3
Madagascar
3
Ukraine
2
China
2
Syria
2
Iran
2
Senegal
2
Malawi
2
Zimbabwe
2
Qatar
2
USA
2
Jordan
2
Germany
2
Saudi Arabia
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Lebanon
2
Yemen
2
Zambia
2
Iraq
2
Ecuador
2
North Macedonia
1
Mexico
1
Lesotho
1
Australia
1
Albania
1
Burkina Faso
1
Afghanistan
1
Peru
1
Morocco
1
Italy
1
Cambodia
1
Eastern Europe and Central Asia
1
North America
1
Denmark
1
France
1
Tunisia
1
Vietnam
1
Russia
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Georgia
1
Mali
1
Angola
1
Chad
1
Libya
1
Botswana
1
South Sudan
1
Somalia
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
147
Clinical Guidelines
67
Public Health
42
Key Resources
41
Pharmacy & Technologies
11
Capacity Building
9
Women & Child Health
9
Toolboxes
Planetary Health
107
Rapid Response
98
NTDs
83
COVID-19
76
AMR
75
Ebola
41
Global Health Education
27
Zika
25
Natural Hazards
9
TB
9
Health Financing Toolbox
8
Cholera
6
Caregiver
6
Conflict
5
Specific Hazards
4
Refugee
3
Pharmacy
3
Polio
3
HIV
2
Mental Health
1
NCDs
1
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
Brucellosis is widespread in both humans and livestock in many developing countries. The authors have performed a series of epidemiological studies on brucellosis in agro-pastoral areas in Tanzania since 2015, with the aim of the disease control. Previously, the potential of a community-based brucel...
As the world recovers from the shock of the COVID-19 pandemic and reflects on lessons learnt from failure of global public health systems to contain the global outbreak of SARS-CoV-2, new infectious disease threats, caused by movement of people globally, remain omnipresent, and repeated calls for mo...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subnational jurisdiction (typically second-tier) reaches the milestone for interruption of transmission, i....
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
In India, in response to the above and guided by our counterparts in the government of India, the UN agencies have developed the Novel Coronavirus Disease Joint Health Response Plan by UN Agencies and Partners, led by WHO-India, in close collaboration with the Ministry of Health and Family Welfare, ...
Healthy people, healthy animals and a healthy environment worldwide with the One Health approach.
The COVID-19 pandemic has drastically demonstrated just how close the link is between humans, animals, and the environment, and has highlighted and aggravated existing challenges. The destruction of na...
In this era, grand challenges lies in biodiversity loss, climate change, and global noncommunicable diseases signify that planet and humanity are in crisis. Scholarly evidence from human and animal kingdom suggest that there is an optimism in planetary health which can provide a unique and novel con...
The One Health approach can help achieve progress and promotes synergies on national and global priorities by generating synergies at the human-animal-environmental interface. While evidence is still scare, it is likely that the approach is highly cost-effective and improves effectiveness of core pu...
Traditional food markets play important economic, cultural, and social role and are sources of livelihood for millions of people in urban and rural areas. The manual Five keys for safer traditional food markets: risk mitigation in traditional food markets in the Asia-Pacific Region aims to support a...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
Benchmarking is a strategic process often used by businesses and institutes to standardize performance in relation to the best practices of their sector. The World Health Organization (WHO) and partners have developed a tool with a list of benchmarks and corresponding suggested actions that can be a...
